ofloxacin has been researched along with tobramycin in 69 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (2.90) | 18.7374 |
1990's | 18 (26.09) | 18.2507 |
2000's | 33 (47.83) | 29.6817 |
2010's | 16 (23.19) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N | 1 |
Amblard, M; Bastide, L; Gualtieri, M; Leonetti, JP; Martinez, J; Pugniere, M; Roquet, F; Villain-Guillot, P | 1 |
Bouza, E; Cercenado, E; Coll, P; Gutiérrez, O; Juan, C; Navarro, F; Oliver, A; Pérez, JL | 1 |
Andres, P; Centrón, D; Galas, M; Guerriero, L; Petroni, A; Quiroga, C; Quiroga, MP; Soler Bistué, AJ; Tokumoto, M; Tolmasky, ME; Vargas, LJ; Zorreguieta, A | 1 |
Chen, T; Khalil, H; Riffon, R; Wang, R; Wang, Z | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Badur, S; Cagatay, AA; Carrër, A; Eraksoy, H; Nordmann, P; Poirel, L | 1 |
Cattoir, V; Nordmann, P; Poirel, L | 1 |
Kirikae, T; Kitao, T; Miyoshi-Akiyama, T | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Bera, S; Mondal, D | 1 |
Gwon, A | 1 |
Gritz, DC; Gwon, A; Hubbard, BB; Lee, TY; McDonnell, PJ; Tang-Liu, D | 1 |
Maiche, AG; Teerenhovi, L | 1 |
Richman, J; Tang-Liu, D; Zolezio, H | 1 |
Beckman, G; Lima, PH; Nelson, JD; Silverman, V | 1 |
Chan, MK; Cheng, IK; Ng, WS | 1 |
Daschner, F; Kropec, A | 1 |
Grohe, K; Metzger, KG; Schacht, P; Zeiler, HJ | 1 |
Alfonso, E; Fink, NE; Maguire, MG; McDonnell, P; O'Brien, TP | 1 |
Discepola, MJ; Goldstein, DA; Jackson, WB; Kirsch, LS | 1 |
Gordon, YJ; Schwob, DL; Tang-Liu, DD; Usansky, JI | 1 |
Baker, RS; Casey, R; Flowers, CW; Fong, DS; Wilson, MR | 1 |
Flynn, CM; Johnson, DM; Jones, RN | 1 |
Durmaz, B; Durmaz, R; Günal, S; Hepsen, IF; Marol, S; Oram, O | 1 |
Majtán, V; Majtánová, L | 1 |
Beck, R; Drewelow, B; Guthoff, R; Hehl, EM; Kundt, G; Luthardt, K | 1 |
Igari, J; Nakamura, A; Oguri, T; Tabe, Y | 1 |
Beck, R; Drewelow, B; Guthoff, R; Hehl, EM; Luthard, K | 1 |
Ahuja, R; Panda, A; Sastry, SS | 1 |
Alexandrakis, G; Alfonso, EC; Miller, D | 1 |
Hostacká, A | 1 |
Lewis, K; Spoering, AL | 1 |
Ishii, Y; Kobayashi, T; Matsumoto, T; Miyazaki, S; Tateda, K; Yamaguchi, K | 1 |
Caballero, AR; Dajcs, JJ; Girgis, DO; Ke, TL; Moreau, JM; O'Callaghan, RJ; Schlech, BA; Stroman, DW; Thibodeaux, BA | 1 |
Baeyens, V; Buri, P; Felt, O; Gurny, R | 1 |
Fleiszig, SM; Lee, EJ; Mendoza, MN; Truong, TN | 1 |
Wu, XD; Yang, YH; Yao, K; Zhang, Z | 1 |
Field, TR; Moriarty, TF; Ramage, G; Storey, DG; Tunney, MM | 1 |
Burgess, DS; Hall, RG | 1 |
Fleisher, KE; Glickman, R; Hirsch, DL; Pahlavi, IA | 1 |
Alió, JL; Ferrer, C; Montero, J; Rodríguez, A; Ruiz-Moreno, JM | 1 |
Aktas, E; Durmaz, R; Kalcioglu, MT; Ozturan, O | 1 |
Adam, HJ; Laing, N; Mayer, M; Zhanel, GG | 1 |
Constantinou, M; Daniell, M; Snibson, GR; Taylor, HR; Vu, HT | 1 |
Eisen, L; Kim, J; Rosenberg, J | 1 |
Naranjo-Tackman, R; Stangogiannis-Druya, C; Stangogiannis-Druya, E; Vanzzini, V; Villar-Kurí, J | 1 |
Kim, EC; Kim, MS | 2 |
Dudley, MN; Griffith, DC; Miller, CE; Nolan, TG; Sabet, M; Senekeo-Effenberger, K | 1 |
Li, R; Liu, C; Sun, XG; Wang, ZQ | 1 |
Otuk, G; Ozbek, B | 1 |
Dai, YH; Huang, YS; Lan, J; Sun, SY; Xie, LX | 1 |
Balidis, MO; Mangioris, GF; Papadopoulos, NT; Papadopoulou, DN; Poulas, JL; Seiler, T | 1 |
Gordon, YJ; Kowalski, RP; Mah, FS; Romanowski, EG; Shanks, RM | 1 |
Cox, JC; Drachman, DA; Hibbard, ML; Kopelman, TR; Maly, TJ; Matthews, MR; O'Neill, PJ; Quan, AN; Vail, SJ | 1 |
Dudley, MN; Griffith, DC; Lomovskaya, O; Sabet, M; Tarazi, Z; Tsivkovskii, R | 1 |
Drewelow, B; Guthoff, RF; Mundkowski, RG; Schittkowski, MP; Wacke, R | 1 |
Drewelow, B; Guthoff, RF; Schittkowski, MP; Wacke, R | 1 |
Alba, LR; Jia, H; Kubin, CJ; Yoko Furuya, E | 1 |
Bai, N; Cai, Y; Kan, Q; Liang, B; Nie, X; Wang, R; Yang, J | 1 |
Chen, ZJ; Han, L; Sun, ST; Wang, LY; Yue, J; Zhang, YQ | 1 |
Grasso, DL; Lora, L; Muzzi, E; Orzan, E; Parentin, F; Pelos, G; Pensiero, S; Trabalzini, F | 1 |
Romero-Trevejo, JL; Somavilla-Lupiáñez, J | 1 |
Abdelkhalek, A; Bergstrom, BE; Hammac, GK; Seleem, MN; Townsend, WM; Younis, W | 1 |
1 review(s) available for ofloxacin and tobramycin
Article | Year |
---|---|
Insights of synthetic analogues of anti-leprosy agents.
Topics: Humans; Leprostatic Agents; Leprosy; Structure-Activity Relationship | 2019 |
12 trial(s) available for ofloxacin and tobramycin
Article | Year |
---|---|
Ofloxacin vs tobramycin for the treatment of external ocular infection. Ofloxacin Study Group II.
Topics: Blepharitis; Colony Count, Microbial; Conjunctiva; Conjunctivitis, Bacterial; Corneal Ulcer; Double-Blind Method; Eyelids; Humans; Microbiological Techniques; Ofloxacin; Ophthalmic Solutions; Tobramycin; Treatment Outcome | 1992 |
Empiric treatment of serious infections in patients with cancer: randomised comparison of two combinations.
Topics: Administration, Oral; Cefotaxime; Drug Synergism; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Neoplasms; Neutropenia; Ofloxacin; Tobramycin | 1991 |
A randomized prospective trial of three different regimens of treatment of peritonitis in patients on continuous ambulatory peritoneal dialysis.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Bacteria; Cephalothin; Drug Therapy, Combination; Female; Humans; Injections, Intraperitoneal; Male; Middle Aged; Ofloxacin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prospective Studies; Randomized Controlled Trials as Topic; Rifampin; Tobramycin | 1990 |
Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Cefazolin; Cephalosporins; Cornea; Corneal Ulcer; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Male; Middle Aged; Ofloxacin; Ophthalmic Solutions; Prospective Studies; Tobramycin; Treatment Outcome | 1995 |
Perioperative ofloxacin vs. tobramycin: efficacy in external ocular adnexal sterilization and anterior chamber penetration.
Topics: Adult; Aged; Aged, 80 and over; Anterior Chamber; Aqueous Humor; Bacteria; Conjunctiva; Double-Blind Method; Drug Therapy, Combination; Erythromycin; Eyelids; Female; Humans; Male; Middle Aged; Ofloxacin; Ointments; Ophthalmic Solutions; Sterilization; Tobramycin | 1995 |
Comparative tear concentrations over time of ofloxacin and tobramycin in human eyes.
Topics: Adolescent; Adult; Double-Blind Method; Female; Half-Life; Humans; Male; Middle Aged; Ofloxacin; Reference Values; Tears; Time Factors; Tobramycin | 1994 |
Aqueous humor penetration of topically applied ciprofloxacin, ofloxacin and tobramycin.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Aqueous Humor; Biological Assay; Ciprofloxacin; Female; Humans; Male; Middle Aged; Ofloxacin; Tobramycin | 1997 |
Improved penetration of aminoglycosides and fluorozuinolones into the aqueous humour of patients by means of Acuvue contact lenses.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Aqueous Humor; Ciprofloxacin; Contact Lenses, Hydrophilic; Drug Delivery Systems; Eye Infections; Female; Gentamicins; Humans; Kanamycin; Male; Middle Aged; Ofloxacin; Ophthalmic Solutions; Staphylococcus epidermidis; Tobramycin | 1999 |
Comparison of topical 0.3% ofloxacin with fortified tobramycin plus cefazolin in the treatment of bacterial keratitis.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Cefazolin; Cephalosporins; Corneal Ulcer; Double-Blind Method; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Male; Middle Aged; Ofloxacin; Ophthalmic Solutions; Prospective Studies; Staphylococcal Infections; Tobramycin; Visual Acuity | 1999 |
[Aqueous humor penetration of topically applied ofloxacin, ciprofloxacin and tobramycin].
Topics: Administration, Topical; Aged; Aqueous Humor; Ciprofloxacin; Endophthalmitis; Female; Humans; Male; Middle Aged; Ofloxacin; Tobramycin | 2003 |
Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Aza Compounds; Bacteria; Cefazolin; Child; Cornea; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Ofloxacin; Prospective Studies; Quinolines; Tobramycin; Treatment Outcome | 2007 |
[Study of different methods in reducing conjunctival bacteria before cataract surgery].
Topics: Aged; Antibiotic Prophylaxis; Cataract; Cataract Extraction; Conjunctiva; Humans; Levofloxacin; Middle Aged; Ofloxacin; Tobramycin | 2009 |
56 other study(ies) available for ofloxacin and tobramycin
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal | 2007 |
Structure-activity relationships of phenyl-furanyl-rhodanines as inhibitors of RNA polymerase with antibacterial activity on biofilms.
Topics: Animals; Anti-Bacterial Agents; Biofilms; CHO Cells; Cricetinae; Cricetulus; DNA-Directed RNA Polymerases; Furans; Gram-Positive Bacteria; Microbial Sensitivity Tests; Rhodanine; Staphylococcus epidermidis; Structure-Activity Relationship | 2007 |
Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Chromosomes, Bacterial; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Integrons; Molecular Epidemiology; Molecular Sequence Data; Mutation; Plasmids; Polymerase Chain Reaction; Porins; Pseudomonas aeruginosa; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Spain | 2007 |
Complex class 1 integrons with diverse variable regions, including aac(6')-Ib-cr, and a novel allele, qnrB10, associated with ISCR1 in clinical enterobacterial isolates from Argentina.
Topics: Alleles; Amino Acid Sequence; Argentina; Bacterial Proteins; Base Sequence; beta-Lactamases; Cross Infection; DNA Transposable Elements; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Analysis, DNA; Sequence Homology, Nucleic Acid | 2007 |
Synergy between polyethylenimine and different families of antibiotics against a resistant clinical isolate of Pseudomonas aeruginosa.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbenicillin; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Novobiocin; Ofloxacin; Piperacillin; Polyethyleneimine; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Ticarcillin; Tobramycin | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Genetic; Turkey | 2008 |
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids | 2008 |
AAC(6')-Iaf, a novel aminoglycoside 6'-N-acetyltransferase from multidrug-resistant Pseudomonas aeruginosa clinical isolates.
Topics: Acetylation; Acetyltransferases; Aminoglycosides; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Integrons; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Topical ofloxacin in the treatment of Pseudomonas keratitis in a rabbit model.
Topics: Administration, Topical; Animals; Aqueous Humor; Chromatography, High Pressure Liquid; Disease Models, Animal; Eye Infections, Bacterial; Keratitis; Ofloxacin; Pseudomonas Infections; Rabbits; Tobramycin | 1992 |
Comparison of ofloxacin, gentamicin, and tobramycin concentrations in tears and in vitro MICs for 90% of test organisms.
Topics: Animals; Biological Assay; Chromatography, High Pressure Liquid; Female; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Ofloxacin; Rabbits; Radioimmunoassay; Spectrometry, Fluorescence; Tears; Tobramycin | 1990 |
Corneal epithelial wound healing: a tissue culture assay on the effect of antibiotics.
Topics: Analysis of Variance; Animals; Anti-Bacterial Agents; Cell Movement; Cells, Cultured; Cornea; Epithelium; Gentamicins; Ofloxacin; Rabbits; Time Factors; Tobramycin; Wound Healing | 1990 |
In vitro activity of fleroxacin and 6 other antimicrobials against Acinetobacter anitratus.
Topics: Acinetobacter; Anti-Bacterial Agents; Cefepime; Ceftazidime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Enoxacin; Fleroxacin; Humans; Microbial Sensitivity Tests; Ofloxacin; Tobramycin | 1989 |
Assessment of the in vitro and in vivo activity of ciprofloxacin measured against current standards of therapy.
Topics: Ampicillin; Animals; Azlocillin; Blood; Ciprofloxacin; Escherichia coli; Humans; In Vitro Techniques; Mice; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Oxazines; Pseudomonas aeruginosa; Quinolines; Sisomicin; Tobramycin | 1985 |
Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefazolin; Cephalosporins; Clinical Trials as Topic; Corneal Ulcer; Double-Blind Method; Drug Therapy, Combination; Eye Infections, Bacterial; Humans; Ofloxacin; Randomized Controlled Trials as Topic; Tobramycin | 1996 |
In vitro efficacy of levofloxacin alone or in combination tested against multi-resistant Pseudomonas aeruginosa strains.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aztreonam; Ceftazidime; Ciprofloxacin; Drug Resistance, Multiple; Gentamicins; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Piperacillin; Pseudomonas aeruginosa; Tobramycin | 1996 |
Pharmacodynamic parameters of ofloxacin, tobramycin and ceftriaxone and their effect on the biological properties of salmonellae.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Coloring Agents; Congo Red; Microbial Sensitivity Tests; Ofloxacin; Salmonella; Salmonella enteritidis; Salmonella Phages; Salmonella typhimurium; Tobramycin | 1997 |
[Corneal penetration of various aminoglycosides and quinolones].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Aqueous Humor; Cataract Extraction; Ciprofloxacin; Contact Lenses; Cornea; Dose-Response Relationship, Drug; Drug Delivery Systems; Gentamicins; Humans; Microbial Sensitivity Tests; Ofloxacin; Ophthalmic Solutions; Tobramycin | 1998 |
Molecular characterization of epidemic multiresistant Staphylococcus haemolyticus isolates.
Topics: Ampicillin; Anti-Bacterial Agents; Cefazolin; Cefmetazole; Cross Infection; DNA Restriction Enzymes; Drug Resistance, Microbial; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Gentamicins; Hospital Bed Capacity, 500 and over; Humans; Imipenem; Infant, Newborn; Microbial Sensitivity Tests; Neonatal Nursing; Nursing Staff, Hospital; Ofloxacin; Oxacillin; Phylogeny; Staphylococcal Infections; Staphylococcus; Tobramycin; Vancomycin | 1998 |
Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Ciprofloxacin; Cornea; Corneal Ulcer; Drug Resistance, Microbial; Eye Infections, Bacterial; Florida; Gentamicins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Ofloxacin; Retrospective Studies; Tobramycin | 2000 |
[Effect of ofloxacin, pefloxacin, and tobramycin on the hydrophobicity of Klebsiella pneumoniae].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Dose-Response Relationship, Drug; Klebsiella pneumoniae; Ofloxacin; Pefloxacin; Tobramycin | 1999 |
Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials.
Topics: Animals; Biofilms; Carbenicillin; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Ofloxacin; Peracetic Acid; Plankton; Pseudomonas aeruginosa; Tobramycin | 2001 |
Potential of macrolide antibiotics to inhibit protein synthesis of Pseudomonas aeruginosa: suppression of virulence factors and stress response.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacterial Proteins; Ceftazidime; Cephalosporins; Clarithromycin; Clindamycin; Erythromycin; In Vitro Techniques; Josamycin; Microbial Sensitivity Tests; Minocycline; Ofloxacin; Oleandomycin; Protein Synthesis Inhibitors; Pseudomonas aeruginosa; Time Factors; Tobramycin | 2000 |
The effectiveness of tobramycin and Ocuflox in a prophylaxis model of Staphylococcus keratitis.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Colony Count, Microbial; Corneal Stroma; Eye Infections, Bacterial; Keratitis; Microbial Sensitivity Tests; Ofloxacin; Ophthalmic Solutions; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tobramycin | 2001 |
Delivery of antibiotics to the eye using a positively charged polysaccharide as vehicle.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Biological Availability; Biopolymers; Chitin; Chitosan; Dosage Forms; Drug Delivery Systems; Eye; Male; Molecular Structure; Molecular Weight; Ofloxacin; Rabbits; Solubility; Solutions; Tears; Time Factors; Tobramycin; Treatment Outcome | 2001 |
A comparison of invasive and cytotoxic Pseudomonas aeruginosa strain-induced corneal disease responses to therapeutics.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Cornea; Corneal Ulcer; Disease Models, Animal; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Glucocorticoids; Mice; Mice, Inbred C57BL; Ofloxacin; Prednisolone; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2003 |
Rapid colorimetric assay for antimicrobial susceptibility testing of Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Colony Count, Microbial; Colorimetry; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Reproducibility of Results; Tetrazolium Salts; Tobramycin | 2004 |
In vitro activity of parenteral Beta-lactams, levofloxacin and tobramycin alone or in combination against extended-spectrum Beta-lactamase producing Klebsiella pneumoniae.
Topics: beta-Lactamases; beta-Lactams; Drug Therapy, Combination; Infusions, Parenteral; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Tobramycin | 2004 |
Severe corneal edema after temporomandibular joint reconstruction: report of a case.
Topics: Adolescent; Ankylosis; Anti-Infective Agents; Corneal Edema; Female; Humans; Ofloxacin; Postoperative Complications; Saline Solution, Hypertonic; Temporomandibular Joint Disorders; Tobramycin | 2004 |
Postoperative Corynebacterium macginleyi endophthalmitis.
Topics: Aged; Aqueous Humor; Bacterial Typing Techniques; Cataract Extraction; Chronic Disease; Corynebacterium; Corynebacterium Infections; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Gene Amplification; Humans; Lens Implantation, Intraocular; Male; Ofloxacin; Polymerase Chain Reaction; Postoperative Complications; Tobramycin; Vancomycin; Vitreous Body | 2004 |
In vitro efficacy of the successive or staggered use of eardrops.
Topics: Acetic Acid; Adjuvants, Pharmaceutic; Administration, Topical; Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Dexamethasone; Drug Administration Schedule; Escherichia coli; Glucocorticoids; Humans; Microbial Sensitivity Tests; Ofloxacin; Otitis Media, Suppurative; Proteus mirabilis; Pseudomonas aeruginosa; Staphylococcus aureus; Tobramycin | 2006 |
Mutant prevention concentrations of levofloxacin alone and in combination with azithromycin, ceftazidime, colistin (Polymyxin E), meropenem, piperacillin-tazobactam, and tobramycin against Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftazidime; Colistin; Dose-Response Relationship, Drug; Drug Synergism; In Vitro Techniques; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Mutation; Ofloxacin; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Thienamycins; Tobramycin | 2006 |
Moxifloxacin for bacterial keratitis.
Topics: Anti-Infective Agents; Aza Compounds; Bacteria; Cefazolin; Cornea; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Fluoroquinolones; Humans; Moxifloxacin; Ofloxacin; Quinolines; Randomized Controlled Trials as Topic; Tobramycin; Treatment Outcome | 2008 |
[Bacterial corneal ulcer treated with intrastromal antibiotic. Experimental model in vivo].
Topics: Analysis of Variance; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Cornea; Corneal Stroma; Corneal Ulcer; Data Interpretation, Statistical; Disease Models, Animal; Female; Gentamicins; Ofloxacin; Prospective Studies; Pseudomonas Infections; Rabbits; Tobramycin; Treatment Outcome | 2009 |
Bilateral acanthamoeba keratitis after orthokeratology.
Topics: Acanthamoeba Keratitis; Biguanides; Contact Lenses, Extended-Wear; Drug Therapy, Combination; Female; Functional Laterality; Humans; Levofloxacin; Ofloxacin; Orthokeratologic Procedures; Tobramycin; Visual Acuity; Young Adult | 2009 |
Efficacy of aerosol MP-376, a levofloxacin inhalation solution, in models of mouse lung infection due to Pseudomonas aeruginosa.
Topics: Administration, Inhalation; Aerosols; Animals; Anti-Bacterial Agents; Aztreonam; Disease Models, Animal; Female; Levofloxacin; Lung Diseases; Mice; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2009 |
[Analysis on the susceptibility of fusidic acid for common gram positive bacteria].
Topics: Anti-Bacterial Agents; Fusidic Acid; Gram-Positive Bacteria; Microbial Sensitivity Tests; Ofloxacin; Staphylococcus; Tobramycin; Vancomycin | 2009 |
Bilateral acanthamoeba keratitis after orthokeratology.
Topics: Acanthamoeba Keratitis; Antiprotozoal Agents; Biguanides; Drug Therapy, Combination; Escherichia coli Infections; Female; Functional Laterality; Humans; Levofloxacin; Microscopy, Phase-Contrast; Ofloxacin; Orthokeratologic Procedures; Tobramycin; Visual Acuity; Young Adult | 2010 |
Post-antibiotic effect of levofloxacin and tobramycin alone or in combination with cefepime against Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Time Factors; Tobramycin | 2009 |
Corneal infiltrates after corneal collagen cross-linking.
Topics: Adult; Collagen; Corneal Diseases; Corneal Stroma; Cross-Linking Reagents; Drug Therapy, Combination; Female; Humans; Keratoconus; Ofloxacin; Photosensitizing Agents; Postoperative Complications; Riboflavin; Tobramycin; Ultraviolet Rays | 2010 |
Topical levofloxacin 1.5% overcomes in vitro resistance in rabbit keratitis models.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Cefazolin; Ciprofloxacin; Colony Count, Microbial; Corneal Stroma; Corneal Ulcer; Disease Models, Animal; Drug Resistance, Bacterial; Eye Infections, Bacterial; Levofloxacin; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tobramycin; Vancomycin | 2010 |
Empiric, broad-spectrum antibiotic therapy with an aggressive de-escalation strategy does not induce gram-negative pathogen resistance in ventilator-associated pneumonia.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Bacterial; Gram-Negative Bacteria; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pneumonia, Ventilator-Associated; Retrospective Studies; Tobramycin | 2010 |
Levofloxacin reduces inflammatory cytokine levels in human bronchial epithelia cells: implications for aerosol MP-376 (levofloxacin solution for inhalation) treatment of chronic pulmonary infections.
Topics: Administration, Inhalation; Aerosols; Anti-Inflammatory Agents; Cell Line; Chronic Disease; Epithelial Cells; Gene Expression Profiling; Humans; Interleukin-6; Interleukin-8; Levofloxacin; Ofloxacin; Pneumonia; Tobramycin | 2011 |
In vitro kinetics of delivery of tobramycin and ofloxacin from osmotic hydro gel expanders.
Topics: Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Delayed-Action Preparations; Drug Delivery Systems; Fluorescence Polarization Immunoassay; Hydrogels; Kinetics; Methylmethacrylate; Ofloxacin; Osmosis; Povidone; Solubility; Solutions; Tobramycin | 2011 |
[Hydrogelexpander as drug delivery system for antibiotics].
Topics: Administration, Ophthalmic; Algorithms; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Drug Carriers; Drug Delivery Systems; Fluorescence Polarization Immunoassay; Humans; Hydrogels; Infant, Newborn; Metabolic Clearance Rate; Ofloxacin; Surgical Wound Infection; Tobramycin | 2012 |
Lack of significant variability among different methods for calculating antimicrobial days of therapy.
Topics: Adult; Anti-Infective Agents; Ceftriaxone; Drug Dosage Calculations; Humans; Kidney Diseases; Ofloxacin; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Time Factors; Tobramycin; Vancomycin | 2012 |
Mutant prevention concentration of colistin alone and in combination with levofloxacin or tobramycin against multidrug-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Colistin; Drug Interactions; Drug Resistance, Multiple, Bacterial; Humans; Levofloxacin; Microbial Sensitivity Tests; Mutation; Ofloxacin; Selection, Genetic; Tobramycin | 2012 |
[The changes of ocular bacterial isolates and in vitro antimicrobial susceptibility in the past six years].
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Eye; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Retrospective Studies; Staphylococcus epidermidis; Tobramycin | 2012 |
Bilateral orbital preseptal cellulitis after combined adenotonsillectomy and strabismus surgery--case report and pathogenetic hypothesis.
Topics: Adenoidectomy; Anti-Bacterial Agents; Ceftriaxone; Child, Preschool; Dexamethasone; Drug Therapy, Combination; Glucocorticoids; Humans; Male; Ofloxacin; Ophthalmologic Surgical Procedures; Orbital Cellulitis; Strabismus; Tobramycin; Tonsillectomy; Treatment Outcome | 2013 |
Canaliculitis due to Gemella haemolysans in a single isolate.
Topics: Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Canaliculitis; Combined Modality Therapy; Curettage; Dexamethasone; Female; Gemella; Gram-Positive Bacterial Infections; Humans; Ofloxacin; Tobramycin | 2018 |
Antibacterial activity and safety of commercial veterinary cationic steroid antibiotics and neutral superoxidized water.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Cations; Cell Line; Dog Diseases; Dogs; Drug Resistance, Microbial; Eye; Eye Infections, Bacterial; Gentamicins; Humans; Hydrogen Peroxide; Mice; Microbial Sensitivity Tests; Ofloxacin; Ophthalmic Solutions; Steroids; Tobramycin; Veterinary Drugs | 2018 |